Genolution (225220.KQ) Stock Price

Genolution Price

CLOSED
1,500.00
​
Market closed

Revenue has compounded at 22.6% per year over the past 9 years to 9.40 B KRW. Earnings per share have grown at 93.3% per year over the last 6 years. Genolution's net margin stands at -123.8%, down from 47.2% several years earlier. Genolution currently offers a dividend yield of about 6.60%. The payout ratio is around 8% of earnings.

Genolution stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution business model & stock analysis

Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry.

Frequently asked questions about Genolution

Converted at the current exchange rate, the Genolution share trades at 1.01 EUR (1,500.00 KRW).

The revenue cannot currently be calculated for Genolution.

The profit cannot currently be calculated for Genolution.

The P/E ratio cannot be calculated for Genolution at the moment.

The P/S cannot be calculated for Genolution currently.

The Eulerpool Quality Score for Genolution is 1/10.

The ISIN of Genolution is KR7225220003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Genolution is 225220.KQ. The ticker symbol is used to trade Genolution shares on the stock exchange.

Fair ValueTerminal
1,230.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
108.10 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Aug 3, 2015
ISIN
KR7225220003
Cusip
Y2R9RC105
Market capitalization
27.08 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.40
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-17.02 %
Dividend
Dividend yield
0.00 %
Payout Ratio
8.15 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 22, 2026, 1:48 AM

Genolution Peer Group

Genolution FIGI

225220:KS · BBG009Q078P9225220:KQ · BBG009Q078R7

All fundamentals and in-depth analysis of Genolution

Our stock analysis for Genolution stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genolution. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.